Novartis`s Kedalion Buy Could Revive Prospects For Xiidra
04 Jul 2022 //
SCRIP
Novartis acquires Kedalion Therapeutics and its innovative ocular delivery platform
30 Jun 2022 //
PRESS RELEASE
04 Jul 2022 //
SCRIP
30 Jun 2022 //
PRESS RELEASE